Safety of high-dose intravitreal triamcinolone acetonide as low-cost alternative to anti-vascular endothelial growth factor agents in lower-middle-income countries.
Safety of high-dose intravitreal triamcinolone acetonide as low-cost alternative to anti-vascular endothelial growth factor agents in lower-middle-income countries. — المؤلف: Ghoraba, Hammouda Hamdy — Clinical ophthalmology (Auckland, N.Z.) 2018
- المؤلف
- Ghoraba, Hammouda Hamdy
- النشر
- Clinical ophthalmology (Auckland, N.Z.) 2018
- الوصف
- 2383-2391 p.